Publication | Open Access

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

VaccinationVaccine SafetyVaccine DevelopmentVaccine TargetImmunologyVaccine TestingVirologyHealthy Ugandan AdultsMedicineVaccine ResearchPhase 1Dose-escalation Clinical Trial